# Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

> **NCT07209917** · NA · RECRUITING · sponsor: **University of California, Irvine** · enrollment: 420 (estimated)

## Conditions studied

- Cervical Cancer
- Human Papillomavirus (HPV) Infection
- Human Immunodeficiency Virus (HIV) Infection

## Interventions

- **BEHAVIORAL:** ASHA-Health HPV Intervention
- **BEHAVIORAL:** Enhanced Standard of Care (SOC+)

## Key facts

- **NCT ID:** NCT07209917
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2029-08-31
- **Final completion:** 2030-07-31
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2026-02-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07209917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07209917, "Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07209917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*